Paladin taps Wyeth for OTC products
This article was originally published in Scrip
Executive Summary
Paladin Labs has acquired a number of Wyeth's Canadian-marketed products in a move that will strengthen its OTC business. The deal for an undisclosed amount includes the pain relief products Anacin (acetylsalicylic acid) and Anbesol (benzocaine).